Deferasirox
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Deferasirox is a prescription medication that acts as an iron chelator to treat iron overload in patients with conditions like thalassemia. Available as oral tablets for suspension in 125mg, 250mg, and 500mg strengths, it's manufactured by Glenmark Pharmaceuticals Inc., USA, under ANDA209433. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Deferasirox
Access the FDA dataset for Deferasirox — ANDA 203560 submitted by Mylan Institutional LLC
Modified Oct 29, 2026